POST Online Media Lite Edition



 

Experimental urine test identifies 92% of men with elevated PSA levels

Staff writer |
An experimental urine test that detects genetic changes associated with prostate cancer identified 92 percent of men with elevated PSA (prostate-specific antigen) levels who had high-grade cancers.

Article continues below






"The test has the potential to be a significant improvement over PSA alone in distinguishing between low- and high-grade prostate cancer, especially in the PSA gray zone patient. It could reduce hundreds of thousands of invasive biopsies each year.

Given the pain and risks associated with performing a prostate biopsy, that's not a trivial thing," said first author James McKiernan, MD, the John K. Lattimer Professor and chair of urology at Columbia University Medical Center (CUMC) and urologist-in-chief at NewYork-Presbyterian/Columbia.

In addition, the test is the only urine-based assay that does not require a digital rectal exam prior to collection and is easily integrated in the clinic environment.

Although the PSA blood test is commonly used to screen for prostate cancer, its value has come under question.

An elevated PSA level—above 4 ng/mL—only indicates that a patient may have cancer and does not reliably distinguish between low-grade cancer, which can be monitored without active treatment, and high-grade disease, which requires aggressive treatment with surgery or radiation therapy.

And, because PSA tests yield a high number of false positive results—only 25 percent of men with an elevated PSA level have prostate cancer—the U.S. Preventive Services Task Force recommends against PSA-based screening.

The only way to definitively diagnose prostate cancer is with a tissue biopsy, a painful procedure that carries a substantial risk of bleeding and infection and a very small chance of death.

"Consequently, men with high PSA levels are typically advised to have a biopsy, even though most have no cancer at all, or have a type of disease that can be monitored without treatment," said Dr. McKiernan.

"In other words, a lot of men are undergoing unnecessary biopsies."

In the study, prostate biopsy results from 774 men with PSA levels between 2 and 10 were compared with a composite score based on results of the urine test plus other risk factors, including PSA level, age, race, and family history of the disease.

Using data from 255 of the men, the researchers first set a cut-off score of 15.6 that identified over 90 percent of men found to have high-grade cancer. The researchers then assessed the test's performance among the remaining 519 men using the designated cut-off score.

A score above 15.6 was used to predict the presence of high-grade cancer (Gleason Score greater or equal to 7); a score equal to or below 15.6 was used to predict the presence of low-grade cancer or no disease.

This analysis showed that the test correctly identified 92 percent of men with high-grade cancer. However, the test also predicted high-grade cancer in 66 percent of men whose biopsies revealed low-grade or no cancer. In clinical practice, use of the test would have spared 27 percent of men from having an unnecessary prostate biopsy.

Among the 138 men who received a low test score, predicting low-grade or no cancer, 91 percent had no cancer or low-grade cancer that didn't require immediate treatment. "By adding this test to our evaluation, men who receive a low score could potentially choose to forgo a biopsy," Dr. McKiernan says.

Of the 12 men who had high-grade cancer but received a low test score, nine had moderately aggressive cancer that would likely have been detected with follow-up monitoring. The remaining three had a higher risk of cancer.

The test, called ExoDxTM Prostate(IntelliScore), detects RNA from three genes (ERG, PCA3, and SPDEF) that have been linked to the development and progression of prostate cancer.

The RNA is encapsulated in lipid membrane-coated structures called exosomes that are excreted by cancer cells into urine. The test, developed by Exosome Diagnostics of Cambridge, Mass, is the first urine-based test for prostate cancer that does not require a digital rectal exam or prostate massage before sample collection. Additional clinical trials to obtain FDA approval are being planned.

Based on the current study, the test's AUROC score, which is a measure of how well the test plus PSA and risk factors distinguishes men with high-grade disease from men without, was superior to that of the current standard of care, at 0.72 versus 0.63. A test with an AUROC score of 1.0 is perfect; a test that performs no better than random guessing has a score of 0.5.

Prostate cancer is the most common solid malignancy and the second leading cause of cancer death in men worldwide, with over a million new cases and approximately 300,000 deaths in 2014, according to the researchers.

Approximately two million transrectal ultrasound-guided prostate biopsies are performed each year in the U.S. and Europe.


What to read next

Enhanced test for urinary tract infections detects even more bacteria
Kidney disease may boost risk of abnormal heartbeat
Test reveals antibiotic-resistant bacteria in half an hour

U.S.: More than 40 million under threat for severe storms, tornadoes could happen

 
Severe storms could deliver tornadoes, damaging winds and hail from the Gulf Coast to the Midwest from Tuesday afternoon into early Wednesday.
 
 

Latest

New York: Historic arts funding to record number of artists and organizations
Macron: U.S. gas 3-4 times more expensive for us, those are double standards
Thank you, inflation: Record Cyber Monday spending
HSBC to sell Canadian unit to Royal Bank of Canada for $10.1 billion

NEWS

Poland: Criminal group extorted money making advantage of COVID situation

UK: Christmas chaos ahead as Wiltshire parking wardens announce further strikes
Italy: 8 dead, several still missing after deadly Ischia mudslide
South Korea issues return-to-work order to truckers on strike
U.S.: Winter weather conditions for west, severe weather potential for south on Tuesday
World's largest volcano Mauna Loa erupts
 

BUSINESS

One in four U.S. workers still fear catching COVID at work, modest winter surge expected

No vessels left Ukrainian ports on November 28 due to adverse weather
Swedish nuclear reactor to be taken off-grid for repairs
UN and ILO must urgently intervene as South Korea weighs forcing striking drivers back to work, says ITF
More internationally educated family doctors on the way to British Columbia
Department of Health in South Africa to conduct feasibility study on implementing solar panels in hospitals
 

Trending Now

U.S.: More than 40 million under threat for severe storms, tornadoes could happen

Saudi Arabia unveils masterplan for mega Riyadh airport project

New York: Historic arts funding to record number of artists and organizations

One in four U.S. workers still fear catching COVID at work, modest winter surge expected


POLITICS

Tánaiste announces major change for small Irish companies

Commission approves €557 million German support to compensate Deutsche Bahn
Belgian government offers one-off tax-free bonus
Health minister discusses cooperation with French companies for manufacturing in Libya
Saudi Arabia unveils masterplan for mega Riyadh airport project
EU Parliament insists that EU must freeze funding to Hungary
 

Today We Recommend

One in four U.S. workers still fear catching COVID at work, modest winter surge expected


Highlights 

HSBC to sell Canadian unit to Royal Bank of Canada for $10.1 billion

Apollo Endosurgery to be acquired by Boston Scientific, enterprise value $615 million

AstraZeneca to acquire Neogene Therapeutics for up to $320 mln


COMPANIES

Apollo Endosurgery to be acquired by Boston Scientific, enterprise value $615 million

Sibanye-Stillwater begins construction of lithium hydroxide refinery in Finland
Bechtel to build Intel's semiconductor manufacturing facilities in Ohio
Biocytogen Pharmaceuticals enters antibody agreement with ADC Therapeutics
BT announces plan for pay rise of up to 16% for all but highest paid
AstraZeneca to acquire Neogene Therapeutics for up to $320 mln
 

CAREERS

Former UK CMA CEO Andrea Coscelli to join Keystone

US Foods appoints Dave Flitman as CEO
G Mining Ventures appoints Carlos Vilhena to board
Criterium Energy appoints David Dunlop as director
Arthex Biotech appoints Frédéric Legros as chairman
Promontory Therapeutics appoints Stanley J. Musial as CFO
 

ECONOMY

Switzerland's GDP grew by 0.2% in Q3 of 2022

Mexico's exports grow 19.5 pct
Trade between Bulgaria, North Macedonia to exceed EUR 1 Bln in 2022
EU trade with Indo-Pacific region
EU green energy product imports in 2021: 15.2 billion euros
Czech Republic: Economic sentiment ticks up in November
 

EARNINGS

Natuzzi Q3 revenue increased 14.5%

CMA CGM Q3 revenue $19.9 billion
G. Willi-Food Q3 sales increased by 16.6%
Deere Q4 net income $2.246 billion
Nordstrom Q3 net loss $20 million
VMware Q3 revenue $3.21 billion
 

OP-ED

Micromanaging is the worst enemy of efficiency and teamwork

Niger set to monetize massive gas reserves through Saharan natural gas pipeline
Putting the brakes on EV folly that choked the market
Oil discovery in Kavango Basin may mean huge benefits for Namibians
Cape Town and Dubai battle over Africa's energy future
Is America going to lose its superpower status?
 

AGRIFISH

Colombian minister announces short and medium-term measures to help rural producers affected by winter weather

Third stage of vaccination against classical swine fever starts in Brazilian state Alagoas
Australia's fish stocks stable and steady
Australia pledges AUD 2 million to WTO Fisheries Funding Mechanism
Pesticide sales jump by 17% in Switzerland
Tesco announces close to £14 million of additional support for British egg industry
 

LEADERSHIP

Corporate duty waivers limit organic company growth and innovation

Women buy from women, men buy from women and men
How employee opinion impacts CEO dismissal
Keeping it in family can be good news when it comes to CEOs
Over a third of office workers are hybrid 'misfits'
Proxy advisers have inherent incentive to create controversy, study shows
 

CRIME

Meta Ireland fined 265 mln euros for data breach

Ukraine fines Engie, Shell subsidiaries over Nord Stream 2
New Zealand fines Southland fishing company $40,000
Italy's antitrust fines Edison Energia 3.8 mln euros over unfair practices
FTC secures monetary judgment in deceptive energy savings claims case
Croatian Competition Agency fines dairy processing company PIK Rijeka $13,740 for imposing unfair trading practices
 

Magazine

TRAVEL

Weather-resistant ArtWalk Downtown Billings, Montana

Dual branded Courtyard and Residence Inn by Marriott Hotel opens in Montreal
Candlewood Suites Hotel opens in Aberdeen, Md.
Mount Roraima, Venezuela, 7,671 feet above the forest floor
Llao Llao Resort, an exclusive resort in the middle of nowhere
Abu Dhabi welcomes visitors to discover experiences at their own pace
 

SEA, LAND, AIR

New colorful Porsche 718 Style Edition models

2023 Toyota Prius Prime, solar panel roof and reliability
Volvo EX90, a car with updates
Cessna Citation CJ4 Gen2 jet, pursue your business goals while enjoying journey
GMC first Sierra EV marks turning point
BMW M2, fast beast in small package
 

DESIGN

Patchwork carpets, vintage Persian carpets made with unparalleled skill

Real life wallpapers, perfectly executed
A. Lange & Söhne, men's watches with true Saxonian DNA
Nella Vetrina, luxurious Italian designers bathroom vanities and furniture
Karastan rugs, durable and beautiful
Leather bags for every occasion and every life style
 

GADGETS

Take Elektor Fortissimo and make your own high-end amplifier

RangeXTD, a Wi-Fi extender that actually works
Monitor II A.N.C. headphones, iconic Marshall sound
Zebra TC15, a clever mix of a mobile phone and a computer for business use
Bathroom speakers will make your relaxing even better
NAD 399 amplifier, highly efficient and remarkably powerful
 

HEALTH

Strong recommendation for pyronaridine-artesunate in revised WHO Malaria Treatment Guidelines

Pakistan launches anti-polio vaccination drive to inoculate 13.5 mln children
Ibuprofen and similar NSAIDS can be associated with hastened progression of osteoarthritis symptoms
Virgin Islands community encouraged to prevent antimicrobial resistance
Shionogi seeks Japan approval for COVID-19 vaccine
French doctors warn of antibiotics shortage
 

MEANTIME

Astrophysicists hunt for second-closest supermassive black hole

New European supercomputer inaugurated in Italy
European Space Agency presents new generation of astronauts
NASA selects Rocket Lab to launch TROPICS mission
World's heaviest flying bird heals itself with plants used in traditional medicine
James Webb Space Telescope reveals an exoplanet atmosphere as never seen before